| Followers | 200 |
| Posts | 25596 |
| Boards Moderated | 0 |
| Alias Born | 04/03/2010 |
Friday, March 18, 2022 1:42:30 PM
The short argument is that the trial had the partial halt because it failed and this is a long-running scam. Let’s just say that the RA would know long ago, if those were the facts, if it had failed and I doubt very much any solid RA in these relevant markets would allow those sales.
Moreover we know lots of other facts that suggest the short story is extremely unlikely. But it doesn’t stop them from constantly saying it.
As for the delay suggesting “there are any problems” with “the trial”, as someone else said, I don’t think it suggests that at all, not beyond anything that is not already publicly known and in their SEC filings. What we do know is they revised their SAP pursuant to a revised guidance document that was in draft form and should be final now but is not. It was a major change and important and I don’t think anyone ever doubted that either. During this period there was a pandemic, planetary event, entire cities and countries have been in lockdown, the US lost almost a million people… the drug regulators besides being overwhelmed, were quite busy and some things appear to have fallen behind, including policy reform, or that policy in my opinion, should be final. Even the end run of Pazdur to private publication of his segment of FDA’s apparent views, or really the personal views of the various FDA authors, suggests that people even at FDA may be frustrated with the pace, to me.
All IMHO.
Moreover we know lots of other facts that suggest the short story is extremely unlikely. But it doesn’t stop them from constantly saying it.
As for the delay suggesting “there are any problems” with “the trial”, as someone else said, I don’t think it suggests that at all, not beyond anything that is not already publicly known and in their SEC filings. What we do know is they revised their SAP pursuant to a revised guidance document that was in draft form and should be final now but is not. It was a major change and important and I don’t think anyone ever doubted that either. During this period there was a pandemic, planetary event, entire cities and countries have been in lockdown, the US lost almost a million people… the drug regulators besides being overwhelmed, were quite busy and some things appear to have fallen behind, including policy reform, or that policy in my opinion, should be final. Even the end run of Pazdur to private publication of his segment of FDA’s apparent views, or really the personal views of the various FDA authors, suggests that people even at FDA may be frustrated with the pace, to me.
All IMHO.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
